← Back to Bills
HR 9096118th CongressFailed / ExpiredHouse

Pharmacists Fight Back Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Jun 6, 2025
Latest Action Date
Dec 17, 2024

Latest Action

Referred to the Subcommittee on Health.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Pharmacists Fight Back Act (H.R. 9096) is a bill introduced in the 118th Congress aimed at addressing issues related to pharmacists, likely within the health policy area. The bill was referred to the House Subcommittee on Health on December 17, 2024, but no further legislative progress or detailed text is available. The bill is currently classified as failed or expired, and no official summary or full text has been provided, limiting detailed analysis of its provisions or objectives.

Bottom Line

H.R. 9096, the Pharmacists Fight Back Act, was introduced but did not advance beyond referral to a subcommittee and is now considered failed or expired, with no detailed public information on its content.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
  • No official summary or full text of the bill is publicly available, restricting detailed policy analysis.
  • The bill is categorized under the health policy area and is currently marked as failed or expired.
Who Benefits?

["Pharmacists and pharmacy professionals potentially targeted by the bill's provisions", 'Health sector stakeholders interested in pharmacist-related policies']

Potential Concerns

['Lack of publicly available full text and official summary limits understanding of implementation requirements and costs', 'Unclear authority or enforcement mechanisms due to missing bill details', 'Potential oversight challenges given the absence of detailed legislative language']

Political Context

The bill was introduced in the House of Representatives during the 118th Congress and referred to the Subcommittee on Health. It did not progress further and is now classified as failed or expired. No additional legislative actions or debates are recorded in the available data.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['Potential influence on pharmacist professional practices if the bill had provisions affecting their roles or regulations', "Possible impact on health care delivery related to pharmacy services depending on the bill's content"]

GovScope Watchdog Notes

The absence of an official summary and full bill text significantly limits transparency and public understanding of H.R. 9096. This lack of information hinders effective oversight and informed legislative debate. Future transparency efforts should ensure that bill texts and summaries are made available promptly to facilitate accountability.

Passage Likelihood: LowConfidence: 70%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready